Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients.
Katarzyna RomejkoAleksandra RymarzKatarzyna SzamotulskaZbigniew BartoszewiczStanisław NiemczykPublished in: Nutrients (2022)
Our results suggest that OPG can be an independent marker of left ventricular hypertrophy, systolic and diastolic dysfunction of left ventricle and the presence of pericardial fluid in chronic kidney disease patients.
Keyphrases
- left ventricular
- ejection fraction
- end stage renal disease
- blood pressure
- heart failure
- mitral valve
- aortic stenosis
- chronic kidney disease
- newly diagnosed
- acute myocardial infarction
- peritoneal dialysis
- cardiac resynchronization therapy
- oxidative stress
- pulmonary hypertension
- left atrial
- coronary artery disease
- patient reported outcomes
- congenital heart disease